Public Citizen requests bans on Arava, Meridia
From Consumer Advocy Groups:Public Citizen urges ban on Arava. . . According to Public Citizen, 130 cases of severe liver toxicity-including 56 hospitalizations and 12 deaths-have been reported to the FDA since the 1998 introduction of rheumatoid arthritis agent leflunomide (Arava). This equates to six times the number of cases of fatal liver toxicity seen with methotrexate, although 5.5 times more prescriptions for methotrexate were filled over the 3-year comparative period. Public Citizen also says that leflunomide has been associated with 12 cases of Stevens-Johnson syndrome (compared with none reported with methotrexate) and more reports of lymphoma and hypertension.
FDA Approves Subcutaneous Tecentriq to Treat Multiple Cancers
September 13th 2024Tecentriq Hybreza can be administered over seven minutes, compared with 30 to 60 minutes for IV infusion of Tecentriq. There is no word yet on when Tecentriq Hybreza will be available or what the price will be.
Read More
FDA Warns of Liver Injury with Veozah for Hot Flashes
September 12th 2024The FDA has identified a probable case of serious drug induced liver injury that occurred in a woman in the United States who had received Veozah. The agency is requiring additional liver blood testing after starting therapy.
Read More
